Show simple item record

dc.contributor.authorAcheampong, Desmond Omane et al.
dc.description.abstractThe severe form of COVID-19 has significant sex disparities, with high fatalities commonly reported among males than females. The incidence of COVID-19 has also been higher in males compared with their female counterparts. This trend could be attributed to a better responsive and robust immune system in females. Cytokine storm is one of the pathophysiological features of severe COVID-19, and it occurs as a result of over-activation of immune cells leading to severe inflammation and tissue damage. Nevertheless, it is well modulated in females compared to their male counterparts. Severe inflammation in males is reported to facilitate progression of mild to severe COVID-19. The sex hormones, estrogens and androgens which exist in varying functional levels respectively in females and males are cited as the underlying cause for the differential immune response to COVID-19. Evidence abounds that estrogen modulate the immune system to protect females from severe inflammation and for that matter severe COVID-19. On the contrary, androgen has been implicated in over-activation of immune cells, cytokine storm and the attendant severe inflammation, which perhaps predispose males to severe COVID-19. In this review efforts are made to expand understanding and explain the possible roles of the immune system, the sex hormones and the angiotensin-converting enzyme (ACE) systems in male bias to severe COVID-19. Also, this review explores possible therapeutic avenues including androgen deprivation therapy (ADT), estrogen-based therapy, and ACE inhibitors for consideration in the fight against COVID-19.en_US
dc.subjectSystematic Reviewen_US
dc.subjectEvidence-Based Medicineen_US
dc.subjectCoronavirus Infectionsen_US
dc.titleMale predisposition to severe COVID-19: Review of evidence and potential therapeutic prospectsen_US
eihealth.categoryVirus: natural history, transmission and diagnosticsen_US
eihealth.categoryEpidemiology and epidemiological studiesen_US
eihealth.categoryClinical characterization and managementen_US
eihealth.typePublished Articleen_US
eihealth.maincategorySlow Spread / Reducir la Dispersiónen_US
dc.relation.ispartofjournalBiomedicine & pharmacotherapyen_US

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record